Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Survival after intestinal perforation: can it be predicted?

Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DC.

Gynecol Oncol. 2009 Dec;115(3):349-53. doi: 10.1016/j.ygyno.2009.08.013.

2.

Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?

Garg G, Massad LS, Pourabolghasem S, Zhou G, Powell MA, Thaker PH, Hagemann AR, Wilkinson-Ryan I, Mutch DG.

Gynecol Oncol. 2013 Jun;129(3):538-43. doi: 10.1016/j.ygyno.2013.03.004.

3.

Analysis of the efficacy of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) according to the prognostic factors in patients with colorectal perforation.

Sugimoto K, Sato K, Maekawa H, Sakurada M, Orita H, Ito T, Sakamoto K.

Surg Today. 2013 Sep;43(9):1031-8. doi: 10.1007/s00595-012-0399-y.

PMID:
23129028
4.

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.

Kumar A, Kennecke HF, Renouf DJ, Lim HJ, Gill S, Woods R, Speers C, Cheung WY.

Cancer. 2015 Feb 15;121(4):527-34. doi: 10.1002/cncr.29072.

5.

Predictive value of a pathophysiological score in the surgical treatment of perforated diverticular disease.

Setti Carraro PG, Magenta A, Segala M, Ravizzini C, Nespoli A, Tiberio G.

Chir Ital. 1999 Jan-Feb;51(1):31-6.

PMID:
10514914
6.

The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies.

Horowitz NS, Cohn DE, Herzog TJ, Mutch DG, Rader JS, Bhalla S, Gibb RK.

Gynecol Oncol. 2002 Jul;86(1):79-84.

PMID:
12079304
7.

Evaluation of prognostic factors and scoring system in colonic perforation.

Horiuchi A, Watanabe Y, Doi T, Sato K, Yukumi S, Yoshida M, Yamamoto Y, Sugishita H, Kawachi K.

World J Gastroenterol. 2007 Jun 21;13(23):3228-31.

8.

The impact of spontaneous tumour perforation on outcome following colon cancer surgery.

Abdelrazeq AS, Scott N, Thorn C, Verbeke CS, Ambrose NS, Botterill ID, Jayne DG.

Colorectal Dis. 2008 Oct;10(8):775-80. doi: 10.1111/j.1463-1318.2007.01412.x.

PMID:
18266887
9.

Prognostic factors and scoring system for survival in colonic perforation.

Komatsu S, Shimomatsuya T, Nakajima M, Amaya H, Kobuchi T, Shiraishi S, Konishi S, Ono S, Maruhashi K.

Hepatogastroenterology. 2005 May-Jun;52(63):761-4.

PMID:
15966200
10.

Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study.

Artac M, Turhal NS, Kocer M, Karabulut B, Bozcuk H, Yalcin S, Karaagac M, Gündüz S, Isik N, Uygun K.

Tumori. 2014 Mar-Apr;100(2):143-8. doi: 10.1700/1491.16397.

11.

[Analysis about the high risk factors and prognosis of gynecologic cancer with deep venous thrombosis].

Huang J, Yang Z, Zhang J, Gao K, Wang H, Li L.

Zhonghua Fu Chan Ke Za Zhi. 2015 Oct;50(10):762-9. Chinese.

PMID:
26675576
12.

Optimal use of adjuvant chemotherapy in stage II colorectal cancer.

Zhou Z, Wu X, Wang R, Li L, Lu Z, Chen G, Fang Y, Pan Z.

Int J Colorectal Dis. 2011 Jul;26(7):867-73. doi: 10.1007/s00384-011-1177-9.

PMID:
21431851
13.

Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention.

Perri T, Korach J, Ben-Baruch G, Jakobson-Setton A, Ben-David Hogen L, Kalfon S, Beiner M, Helpman L, Rosin D.

Eur J Surg Oncol. 2014 Jul;40(7):899-904. doi: 10.1016/j.ejso.2013.10.025.

PMID:
24268761
14.

Prognostic factors for survival after curative resection of Dukes' B colonic cancer.

Saha AK, Smith KJ, Sue-Ling H, Sagar PM, Burke D, Finan PJ.

Colorectal Dis. 2011 Dec;13(12):1390-4. doi: 10.1111/j.1463-1318.2010.02507.x.

PMID:
21073647
15.

Prognostic factors for survival in colonic perforation.

Kriwanek S, Armbruster C, Beckerhinn P, Dittrich K.

Int J Colorectal Dis. 1994 Aug;9(3):158-62.

PMID:
7814991
16.

Risk factors for postoperative complications in oral cancer and their prognostic implications.

de Melo GM, Ribeiro KC, Kowalski LP, Deheinzelin D.

Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):828-33.

PMID:
11448358
17.

Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement.

Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M, Schorge J, Mueller P, Growdon W.

Gynecol Oncol. 2013 May;129(2):332-5. doi: 10.1016/j.ygyno.2013.02.002.

PMID:
23402902
18.

Postoperative arterial blood lactate level as a mortality marker in patients with colorectal perforation.

Shimazaki J, Motohashi G, Nishida K, Ubukata H, Tabuchi T.

Int J Colorectal Dis. 2014 Jan;29(1):51-5. doi: 10.1007/s00384-013-1738-1.

19.

Use of the APACHE II scoring system to determine mortality of gynecologic oncology patients in the intensive care unit.

Van Le L, Fakhry S, Walton LA, Moore DH, Fowler WC, Rutledge R.

Obstet Gynecol. 1995 Jan;85(1):53-6.

PMID:
7800324
20.

Prognostic factors for mortality in left colonic peritonitis: a new scoring system.

Biondo S, Ramos E, Deiros M, Ragué JM, De Oca J, Moreno P, Farran L, Jaurrieta E.

J Am Coll Surg. 2000 Dec;191(6):635-42.

PMID:
11129812
Items per page

Supplemental Content

Support Center